Overview

A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms

Status:
Completed
Trial end date:
2016-10-28
Target enrollment:
Participant gender:
Summary
This study will be a prospective, randomized, double-blind, placebo-controlled, parallel group, multicenter trial of postmenopausal subjects with an intact uterus.
Phase:
Phase 3
Details
Lead Sponsor:
TherapeuticsMD
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Polyestradiol phosphate
Progesterone